Treatment of anemia in pregnancy with intravenous iron therapy as compared to oral iron therapy.
Phase 3
Completed
- Conditions
- Health Condition 1: null- anemic patients with hemoglobin level between 7 to 11 g/l
- Registration Number
- CTRI/2016/12/007552
- Lead Sponsor
- Dr Shruti Bhavi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 112
Inclusion Criteria
hemoglobin level between 7 t0 11 gm/dl,serum ferritin less than 15 ng/ml,singleton pregnancy.
Exclusion Criteria
patients with history of bleeding tendancy,history of blood transfusion within prior 120 days,hemogolobinopathy or other red cell disorders,allergic asthma.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Intravenous iron sucrose is safe and effective in treatment of iron deficiency anemia in pregnanyTimepoint: Intravenous iron sucrose is safe and effective in treatment of iron deficiency anemia in pregnany.
- Secondary Outcome Measures
Name Time Method Intravenous iron sucrose is indicated in rapid correction of anemia in pregnancy and restoring maternal iron stores.Timepoint: Intravenous iron sucrose improves maternal iron stores.